Results 241 to 250 of about 2,891,562 (358)
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung+6 more
wiley +1 more source
What can early HTA bring to needs-based innovation? [PDF]
Fibla-Reixachs J.
europepmc +1 more source
A Modern Batak Horja: Innovation in Sipirok Adat Ceremonial
Susan Rodgers Siregar
openalex +2 more sources
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim+18 more
wiley +1 more source
Development and validation of an innovation competence instrument for medical mentors in China: a mixed-methods study. [PDF]
Chen G+5 more
europepmc +1 more source
From simple customer to warm user; Or, who cares about the maintenance of community innovations?
Stefan Verhaegh
openalex +2 more sources
Objectives Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centred care and informing local service pathways and care guidelines or standards.
Sonia Ranelli+8 more
wiley +1 more source
Optimizing sustainability performance through digital dynamic capabilities, green knowledge management, and green technology innovation. [PDF]
Al-Husain RA+8 more
europepmc +1 more source
Australia in the 1970's : A Fertile Context for Educational Experimentation and Innovation
J. David Bambach
openalex +2 more sources
Hydroxychloroquine Associated with Lower Glomerular Filtration Rate Decline in Lupus Nephritis
Background Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical. Therefore, we analyzed data from our
Shivani Garg+9 more
wiley +1 more source